The 25th Congress of the European Hematology Association (EHA) 2020, 11–21 June, will see hematology experts from around the globe congregate online for a spectacular show of the latest research outputs.

Key data on novel agents, biomarkers, cellular therapy, patient-reported outcomes, genomic insights, transplant research, and more was showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, VOD, ITP, PNH, thalessemia, and beyond.

View all videos

EHA 2020

The 25th Congress of the European Hematology Association (EHA) 2020
11–21 June 2020

📢VIDEO: @tompowles1 discussing the CheckMate 9ER data presented at #ESMO20!

Click here 👉https://bit.ly/32JDAKZ👈

@VJOncology @myESMO @OncoAlert #LCsm #BCsm #PCsm #scmsm #HNCsm #BTsm #CRCsm #OncoAlert

#SkinCancer updates at #ESMO20: Jeffrey Weber of @nyulangone discusses the 4-year results from the #CheckMate238 trial

Watch the full video here: 👉https://bit.ly/3iMxNdi👈

@VJOncology @myESMO @OncoAlert #OncoAlert #CTsm #MelSM #SkcSM

#LungCancer: @VJOncology had a great chat w/ @DrRoyHerbstYale of @YaleCancer, including fresh updates on the #ADAURA study

Full video here:👉https://bit.ly/2H6ngvp👈

#ESMO20 @VJOncology @myESMO @OncoAlert #OncoAlert #CTsm #LCsm #NSCLC #SLCL

📢VIDEO: @VJOncology caught up with @drenriquegrande to chat about studies in thyroid cancer presented at #ESMO20

Video here: 👍https://bit.ly/3hNIWcD

@VJOncology @myESMO @OncoAlert #HNCsm #OncoAlert

📢💻VIDEO: @oncology_bg discussing shortcomings in study design and the factors that can skew the ESMO-MCBS results

Full interview with @VJOncology here: 👉https://bit.ly/2FQ0RlE👈

@VJOncology @myESMO @OncoAlert #LCsm #BCsm #PCsm #scmsm #HNCsm #BTsm #CRCsm #OncoAlert #ESMO20

Load More

EHA 2020

The 25th Congress of the European Hematology Association (EHA) 2020
11–21 June 2020

The 25th Congress of the European Hematology Association (EHA) 2020, 11–21 June, will see hematology experts from around the globe congregate online for a spectacular show of the latest research outputs.

Key data on novel agents, biomarkers, cellular therapy, patient-reported outcomes, genomic insights, transplant research, and more was showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, VOD, ITP, PNH, thalessemia, and beyond.

View all videos

📢VIDEO: @tompowles1 discussing the CheckMate 9ER data presented at #ESMO20!

Click here 👉https://bit.ly/32JDAKZ👈

@VJOncology @myESMO @OncoAlert #LCsm #BCsm #PCsm #scmsm #HNCsm #BTsm #CRCsm #OncoAlert

#SkinCancer updates at #ESMO20: Jeffrey Weber of @nyulangone discusses the 4-year results from the #CheckMate238 trial

Watch the full video here: 👉https://bit.ly/3iMxNdi👈

@VJOncology @myESMO @OncoAlert #OncoAlert #CTsm #MelSM #SkcSM

#LungCancer: @VJOncology had a great chat w/ @DrRoyHerbstYale of @YaleCancer, including fresh updates on the #ADAURA study

Full video here:👉https://bit.ly/2H6ngvp👈

#ESMO20 @VJOncology @myESMO @OncoAlert #OncoAlert #CTsm #LCsm #NSCLC #SLCL

📢VIDEO: @VJOncology caught up with @drenriquegrande to chat about studies in thyroid cancer presented at #ESMO20

Video here: 👍https://bit.ly/3hNIWcD

@VJOncology @myESMO @OncoAlert #HNCsm #OncoAlert

📢💻VIDEO: @oncology_bg discussing shortcomings in study design and the factors that can skew the ESMO-MCBS results

Full interview with @VJOncology here: 👉https://bit.ly/2FQ0RlE👈

@VJOncology @myESMO @OncoAlert #LCsm #BCsm #PCsm #scmsm #HNCsm #BTsm #CRCsm #OncoAlert #ESMO20

Load More

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter